Browse by author
Lookup NU author(s): Dr Vicky Brocklebank, Professor David KavanaghORCiD
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
© 2014 Royal College of Physicians. Atypical haemolytic uraemic syndrome is a thrombotic microangiopathy with a predominant renal phenotype. Research developments in the last 15 years have led to the elucidation of the role of complement over activation in the pathogenesis of the disease. This was to lead to the successful introduction of targeted pharmacological therapy, in the form of the complement inhibitor, eculizumab.
Author(s): Brocklebank V, Kavanagh D
Publication type: Review
Publication status: Published
Journal: Clinical Medicine
Year: 2014
Volume: 14
Issue: suppl. 6
Pages: s89-s94
Print publication date: 01/12/2014
Acceptance date: 01/01/1900
ISSN (print): 1473-4893
URL: https://doi.org/10.7861/clinmedicine.14-6-s89
DOI: 10.7861/clinmedicine.14-6-s89
PubMed id: 25468928
